Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Chinese officials say 261 foreign nationals from 23 countries are unaccounted for on the Tibetan side of the border after a glacier collapse triggered a mudslide. The disaster has claimed 16 lives in Tibet and many more on the Nepalese side, prompting large-scale rescue mobilization, cross-border aid and warnings about further flooding.
Major mutual funds have kept U.S. softlines names below benchmark weightings for years, with the 25 largest mutual funds holding the sector at roughly 76% of its S&P 500 index weight. Technology-focused flows have contributed to a gradual reduction in the sector's footprint, while Ross Stores has been a notable recipient of improved positioning. Ev…
Venezuela's interim president said a 25-year energy agreement with the United States will focus on developing 17 strategic oilfields, set an initial crude production target of more than 1.5 million barrels per day and preserve Venezuela's sovereignty over its hydrocarbon resources. The accord, described as historic, is presented as a revenue genera…
Insurers tied to Mark Walter face growing funding pressure as a large pool of short-term loans to affiliated firms comes due, according to reporting. Roughly $20 billion of insurance investments connected to Walter-controlled entities are the subject of a federal inquiry that prompted the insurers to reclassify a substantial share of assets as rela…
Bernstein analysts warn that artificial intelligence is creating an expanding memory bottleneck as different AI tasks place distinct demands across the memory hierarchy. Training, inference, retrieval-augmented generation and agentic AI all stress combinations of HBM, system DRAM, local SSDs and networked storage in different ways, prompting vendor…
British far-right commentator Milo Yiannopoulos was deported to the United Kingdom after U.S. immigration authorities detained him at a New Orleans airport. The Department of Homeland Security says he overstayed a lawful entry from May 2019 and failed to appear for an immigration hearing, prompting a final removal order issued in July.
Glencore has booked a provision of about $480 million to absorb its net exposure to iron ore trader Radiant World, which is under intense pressure after allegations of falsified documentation. The move effectively writes down the full net balance between the two firms and comes as relations deteriorate, with Radiant World threatening legal action o…
Iceland held a referendum on Aug. 29 on whether to resume talks with the European Union, with the electorate closely split. Campaign themes centered on the cost of living, high interest rates, sovereignty and control of fishing waters. A Gallup poll shortly before voting showed a small majority opposed reopening negotiations. If approved, a 'yes' w…
Vår Energi's clustered North Sea footprint and growing hub density are converting incremental production into outsized free cash flow. We see an asymmetric reward-risk over the next 180 trading days as the market re-prices the company closer to a cash-flow multiple rather than a pure growth multiple. Entry at $14.50, target $19.00, stop $12.00.
MarketWise is a small-cap subscription software platform that just reported accelerating billings and affirmed a $1.80 annual dividend. The business is generating strong cash flow, valuation is cheap on cash-flow metrics, and the stock yields materially. We outline a buy plan with a tight stop to limit downside and a target near the 52-week high fo…
Revolution Medicines just cleared a major regulatory hurdle with FDA approval of RASONQUE (daraxonrasib) for metastatic pancreatic adenocarcinoma. The approval unlocks what analysts peg as up to $11.5 billion in peak sales and converts the company from a pure clinical-stage name into a commercial oncology contender. Given the stock's recent pullbac…
MaxLinear (MXL) is benefiting from a surge in AI data-center connectivity demand and delivered strong near-term results and guidance. The stock is richly valued on classic multiples, but the business is posting double-digit and even triple-digit growth in its infrastructure products. This idea sizes a long trade aimed at capturing the next 180 trad…
Cytokinetics announced additional positive results from two Phase 3 clinical trials, ACACIA-HCM and MAPLE-HCM, demonstrating that their drug aficamten improved cardiac function and symptoms in patients with non-obstructive and obstructive hypertrophic cardiomyopathy (HCM). Notably, ACACIA-HCM showed aficamten improved cardiac structure and diastoli…
PayPal rallied on solid TPV and a one-off free cash flow beat, but underlying branded checkout weakness, margin pressure, and a failed $60.50 takeover attempt leave the stock vulnerable. Technicals show bearish momentum and elevated short activity. We recommend a tactical short trade sized for a swing window as management execution must prove susta…
Nvidia remains the dominant play in AI datacenter compute. Recent hawkish Fed commentary and a sharp intraday unwind created a tactical buying window near $218. The trade: enter at $217.88, stop $200.00, target $265.00 (mid-term) and extended target $320.00 (long-term). Risk/position sizing and a close watch on macro and data-center guidance are cr…
Hello Group (MOMO) trades deep below historical expectations. With an enterprise value near $1.03B, reported free cash flow of $447M and an earnings profile that makes the stock cheap on multiple metrics, the risk/reward looks favorable for a disciplined long trade. This idea lays out entry, stop, target and the fundamental and technical reasons to…
ServiceNow has shrugged off the 'AI will kill SaaS' narrative. Strong AI monetization, a large backlog and improving technicals make the stock a buy for a position trade. Entry at $144.70, stop $130.00, target $175.00; mid-term catalyst window and optional longer-term upside if billings reaccelerate.
Chevron looks expensive to bid up on speculative geopolitical headlines. The company’s fundamentals are solid, but Venezuelan upside is not a near-term supply solution. For traders, a mid-term short-fade setup offers a defined risk/reward: enter around current levels, stop above the recent swing high, target the 50-day support and dividend yield re…
Element Solutions (ESI) has been punished on merger-related headlines, but its electronics-facing portfolio, solid cash flow, and manageable balance sheet argue for buying weakness. Valuation is not cheap, but the risk/reward looks favorable from current levels with a clear stop and a 180-trading-day horizon.
Goldman Sachs published a research note finding that U.S. inflation expectations have remained broadly anchored even after more than five years of above-target inflation. Using survey analysis and an adapted memory-based model, the bank draws three core lessons about the formation and persistence of expectations and projects inflation to return to …
VCN:CA (Vanguard FTSE Canada All Cap Index ETF) offers a low-cost, high-conviction way to own Canada’s equity market. For investors willing to accept moderate sector concentration risk, a mid-term long trade captures a potential bounce tied to commodity strength and yield-seeking flows.
Minera Alamos (MAIFF) presents a tactical long opportunity after a pullback to intraday support near its 10-day moving average. Technicals show bullish momentum, short interest has risen, and the company trades with limited public-market liquidity — factors that can amplify near-term catalysts tied to project development news. This trade targets a …
<p>Apple is trading at $320.13 with a $4.66 trillion market cap and a premium multiple, but the company's free cash flow of $136.7B, 33.6% return on assets and a new product cycle centered on on-device AI make a buy-with-protection trade attractive. This idea targets a re-test of 52-week highs if product launches land and services growth holds.</p>
Tenax Therapeutics announced additional data from its Phase 3 LEVEL trial evaluating oral levosimendan (TNX-103) in patients with pulmonary hypertension due to heart failure with preserved ejection fraction (PH-HFpEF). While primary endpoints on exercise capacity were not met, subgroup analysis revealed significant improvements in patients with low…
PagSeguro trades at bargain multiples despite mid-single-digit to double-digit revenue growth and margin stability. Elevated short interest and macro worries have pushed the stock below fair-value levels; we see a disciplined long with a $12.50 target and $7.50 stop over a 180 trading-day horizon.
